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• The conditioning of inhaled air during exercise-hyperpnea initiates osmotic 
and vascular events that lead, in susceptible individuals, to airway narrowing. 
• A loss of physical barrier intergrity and impairment in signaling and secretory 
functions of the airway epithelium increases the susceptibility to EIB.  
• Airway smooth muscle contraction and mucin release in individuals with EIB 
are mediated predominantly by release of inflammatory mediators with 
associated activation of neural pathways. 
• Cysteinyl leukotrienes and prostaglandin D2 are the primary inflammatory 





Exercise is a common trigger of bronchoconstriction. In recent years, there has been 
increased understanding of the pathophysiology of exercise-induced 
bronchoconstriction (EIB). While evaporative water loss and thermal changes have 
been recognized stimuli for EIB for almost 50 years, accumulating evidence points 
toward a pivotal role for the airway epithelium in orchestrating the inflammatory 
response linked to EIB. Overproduction of inflammatory mediators, relative 
underproduction of protective lipid mediators, and infiltration of the airways with 
eosinophils and mast cells are all established contributors to EIB. Sensory nerve 
activation and regional airway closure maybe important in EIB, but further research is 
warranted.  




The underlying basis for exercise-induced bronchoconstriction (EIB) is becoming 
increasingly understood. Initial work starting in the 1970s revealed the major 
determinants of EIB in susceptible individuals. The aim of this review is: to examine 
the respective roles of evaporative water loss and thermal changes as stimuli to EIB; 
to provide evidence that loss of physical barrier functions of the epithelium during 
exercise-induced hyperpnea is associated with the development of 
bronchoconstriction in susceptible individuals; to discuss the central role of leukocyte 
activation and the associated generation of lipid mediators and release of neuropetides 
that sustain bronchoconstriction during EIB; and to consider the role that regional 
airway closure may play in the development of EIB. 
 
CONDITIONING THE AIR INSPIRED DURING EXERCISE 
Under most conditions of exercise the air inspired needs to be heated and humidified 
to body conditions [37oC, 100% relative humidity (RH), or 44 mg H2O/L] before it 
enters the alveoli. As a result, heat and water are lost from the airway surface during 
inspiration. The number of generations involved in conditioning depends on the level 
of ventilation reached and sustained during exercise, and the temperature and water 
content of the inspired air.(1) 
 
Heat loss as a stimulus to airway narrowing 
Cooling of the airways, from heat lost through vaporisation of water and from heating 
the inspired air, was initially identified as a potential stimulus for EIB.(2) The 
proposal was subsequently extended to include a rewarming of the airways after 
exercise.(3) (Figure 1) This hypothesis suggested that cooling initiated 
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vasoconstriction during exercise, followed by a reactive (or rebound) hyperaemia at 
the end of exercise.(3) These vascular events are most significant when air of sub zero 
temperature is inspired during intense exercise of 4 minutes or more (4) and when the 
smaller airways are recruited into the conditioning process, but are unlikely to occur 
in temperate or hot environments. These vascular events may be relevant to anyone 
performing vigorous exercise in cold conditions – although people with asthma may 
have a more rapid and exaggerated vascular response (5) –, and may serve to amplify 
airway narrowing in individuals with asthma with EIB.(6)  
 
Water loss as a stimulus to airway narrowing 
It is now well recognised that cooling and rewarming of the airways are not 
prerequisites for EIB. In individuals with asthma, EIB occurs when hot dry air is 
inhaled during exercise (7-9) and when the airways are not cooled below their 
temperature at rest.(10)  
 
The concentration of water in the inspired air is an important determinant of EIB (11), 
with the rate of water loss during exercise relating directly to the severity of the 
airway response in an individual.(12)  Importantly, the stimulus to EIB acts at the 
surface of the airways, because EIB is prevented simply by inhaling fully humidified 
air at body temperature.(11, 13) A loss of water by evaporation, in humidifying large 
volumes of air in a short time, is thought to cause a transient increase in concentration 
of ions (e.g., Na+, Cl-, Ca++) in the airway surface liquid (ASL).(14) (Figure 1) This 
osmotic stimulus occurs after intense exercise when dry air of any temperature (cold 




Because the surface area of the first 10 generations of airways is 742 cm2 and contains 
less than 0.7 ml of ASL (15, 16), only a small loss of water would increase osmolarity 
above the normal value of ~320-340 mosm. A mathematical model, based on in vivo 
observations (17), predicted that breathing air of 26oC and 35% RH at 60 L/min 
would result in a cumulative loss of 0.44 mL per minute from the first 12 generations 
of airways.(18, 19) It is likely that this rate of water loss exceeds the rate of 
replacement across the epithelium, leading to a transient increase in osmolarity of the 
ASL.  
 
Although methodological limitations render the accurate measurement of changes in 
ASL osmolarity difficult (20), there is direct evidence for evaporative water loss from 
the airways involved in conditioning the air. Mucociliary clearance rate was shown to 
be reduced during hyperpnea with dry air (but not humid air).(21) This reduction, 
however, occurred more markedly in people with asthma compared with healthy 
individuals, suggesting that the rate of water movement across the epithelium towards 
the lumen is slower in populations prone to EIB.(21)  
 
An increase in ion concentration of the ASL during exercise would act as an osmotic 
stimulus for transport of water to the airway surface from the epithelial cells and other 
cells on, or near the airway surface. Because the basolateral membrane is less 
permeable to water than the apical membrane, it was proposed that epithelial cells, as 
well as other cells, would have a reduction in volume. (22) It is the regulatory volume 
increase following cell volume decrease that is thought to provide the signal for 
mediator release. The source of water to replace the epithelial cell volume is the 
submucosa and small changes in its osmolarity could be the signal to the increase in 
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bronchial blood flow that occurs when breathing dry air.(23-25) The osmotic stimulus 
to EIB is further supported by evidence that airway narrowing can be provoked in 
asthmatics by inhalation of hyperosmolar saline.(26) Further, the airway response to 
hypertonic saline is related to mast cell number (assessed by brush biopsy).(27) 
Mediators released in response to osmotic challenge with dry powder mannitol (28) 
are the same as exercise (29) and blocked by the same drugs.(30, 31) 
 
The transient increase in osmolarity of ASL during exercise creates an environment 
known to be favourable for release of mediators from cells in, or near the airway 
surface (e.g., epithelial cells, sensory nerves, mast cells and eosinophils). While some 
mediators [prostaglandin E2 (PGE2)] may induce bronchodilation during exercise, 
other mediators [neurokinins, PGD2, cysteinyl leukotrienes (cyst-LTs)] provoke 
airway narrowing by acting, either directly on bronchial smooth muscle or, via 
sensory nerves. (Figure 2) (29, 31)    
 
Temperature as a modulator of time course and severity of EIB 
The severity of EIB is similar in the same individual over a wide range of inspired air 
temperatures, from cool (9oC) to hot (36oC), (Figure 3) providing that the inspired 
water content is low and remains the same. (7-9) This is consistent with the relatively 
constant value measured for water content of expired air (29-33 mg/L), when 
breathing air at 22-40°C that contains <13 mg H2O /L.(24) The maximum airway 
response is thought to occur when generations 10 to 12 are recruited, and this may 
take 8 minutes when the inspired air is warm. It is here, in the non-cartilaginous 
airways, that the density of mast cells is high in individuals with asthma.(32) This 
may explain why warm dry air can still cause a similar fall in expiratory flow to cool 
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air.(8) The cooler the inspired air, the faster the required generations will be recruited, 
and the earlier the response will occur.  
 
EPITHELIAL DYSFUNCTION IN EIB 
The airway epithelium is the first structural barrier to the inhaled environment in the 
airway mucosa. Under normal circumstances, the epithelium forms a highly regulated 
and tight barrier that limits penetration of inhaled allergens, pathogens, pollutants and 
other toxic compounds into the internal lung environment. Exercise hyperpnea can 
cause acute disruption of the airway epithelium (33-35). Shedding of epithelial cells 
into the airway lumen after exercise challenge has been shown in individuals with 
asthma with EIB (36). A (partial) loss of physical integrity of the epithelial barrier is 
likely to disrupt airway homeostasis at a number of levels. Disruption of ASL balance 
(resulting in malfunction of the mucociliary escalator), plasma exudation (resulting in 
edema), and attraction and activation of inflammatory cells in response to injury can 
all compromise airway homeostasis. Instrinsic dysfunction of the airway epithelium – 
as found in individuals with asthma (37) – and/or extreme levels of ventilation – as 
developed by endurance athletes (38) – are likely to increase the susceptibility to 
/extent of airway epithelial injury and, thereby, explain the high prevalence of EIB 
reported in both these populations (39, 40).  
 
Breaking through the epithelial barrier 
As minute ventilation increases during exercise, so does the load of foreign 
substances entering the airways. Disruption of epithelial tight junctions and/or gaps 
into the epithelium facilitates the penetration of foreign substances, enhancing the 
potential for toxic, immune, and inflammatory responses, with ensuing 
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bronchoconstriction in susceptible individuals. During the pollen season, the severity 
of airway narrowing after outdoor exercise is increased in individuals with asthma 
with birch pollen allergy (41). The cellular infiltration and activation of mast cells and 
T cells (and possibly eosinophils) observed during natural allergen exposure in atopic 
individuals with asthma (42) would render the airway smooth muscle more responsive 
to the stress of exercise. Further, common air pollutants and irritants (such as ozone or 
chlorine derivatives) have the potential per se to acutely disrupt the lung epithelial 
barrier (43, 44). Inhalation of noxious airborne agents during exercise hyperpnea 
could therefore aggravate the damage to the epithelium, and increase the risk/severity 
of EIB. In support of this concept, a high prevalence of EIB has consistently been 
reported in athletes who train and compete in polluted environments. (1)  
 
Disturbance of ASL 
Apart from being a barrier, the airway epithelium plays other roles, including 
maintenance of ASL levels (45). Intact epithelial cells sense and autoregulate ASL 
height by active ion transport (46). A damaged airway epithelium would loose its 
ability to tightly regulate water movements, potentiating the osmotic effects of 
exercise hyperpnea and, potentially increasing the severity of EIB. In individuals with 
asthma with EIB, the extent of airway injury (as assessed by the percentage of 
columnar epithelial cells in sputum) at baseline has been shown to correlate with the 
severity of the airway narrowing after exercise (29).  
 
Mucus dysfunction 
Abnormal water movement, as a consequence of airway epithelial injury, also leads to 
alterations in rheological properties of mucus, with subsequent impairement of 
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mucociliary clearance and plug formation. A thicker and more elastic mucus is harder 
to clear from the airways and provides an environment for microbial growth, leading 
to infection and inflammation (47). In children with asthma (a population prone to 
EIB), viral infections of the airways are frequent and commonly associated with 
disease exacerbations (48). Further, in elite athletes with asthma and/or EIB, an 
increase respiratory infection susceptibility has recently been reported (49).  
Mucus plugs could also directly contribute to lumenal obstruction in EIB. In 
individuals with asthma with EIB, exercise was found to initiate the release of 
MUC5AC (i.e., the predominant gel-forming mucin of goblet cells) (50). Moreover, 
an hyper-activity of the mucus-secreting goblets has been reported in both, individuals 
with asthma with EIB (50) and elite athletes (51). Therefore, alterations in mucosal 
rheology secondary to epithelial dysfunction are likely to contribute to airflow 
obstruction and post-exercise symptoms (such as cough and mucus hypersecretion). 
 
Epithelial damage-restitution 
Restitution of the epithelium upon injury is associated with many tissue responses 
including, amongst others, plasma exudation (52). Plasma exudate in the airway 
lumen could not only contribute to EIB through mucosal/submucosal edema, but may 
also exacerbate some of the events described previoulsy (i.e., shedding of epithelium, 
impairment of mucociliary transport and mucus plug formation) (53). Further, plasma 
exudate may cause airway inflammation and constriction due to its content of 
powerful mediators (52). In the context of elite sport, repeated plasma exudation has 
been proposed, via release of a wide range of chemoattractant factors and plasma 
proteins (such as cytokines and growth factors), to contribute to the development of 
EIB (54). In elite athletes, late onset (>25 yr) of EIB is common (55) and a change of 
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the contractile properties of the airway smooth muscle is likely to result from 
combined effects of inflammatory and physical environmental stimuli. In asthma, due 
to pre-existing inflamed airways, the potent plasma-derived proteins-peptides released 
in response to hyperpnea-induced epithelial injury could activate an inflammatory 
cascade, with ensuing bronchoconstriction.  
 
LEUCOCYTE ACTIVATION AS A FUNDAMENTAL MECHANISM OF EIB 
The acute response  
There is strong evidence that the sustained bronchoconstriction following exercise and 
dry air hyperpnea challenges is due to the release of leukocyte-derived inflammatory 
mediators in the airways. Similar evidence indicates that hyperosmolar aerosols lead 
to the release of leukocyte-derived mediators. (28) Specifically, leukocyte-derived 
eicosanoids including the leukotrienes (LT) and prostaglandins (PG) play a pivotal 
role. Following exercise challenge in asthmatics with EIB, there is sustained release 
of cysteinyl LTs (Cys-LTs, LTs C4, D4 and E4) and PGD2 into the conducting 
airways, corresponding with the development of acute bronchoconstriction (29, 31, 
56). The release of these mediators is attenuated under conditions that reduce the 
severity of EIB (29, 31, 56, 57). Pharmacological inhibitors of this pathway 
unequivocally demonstrate that the release of these mediators play a causative role in 
the pathogenesis of EIB. (29, 31, 58) Inhibition of the key initial enzyme in LT 
biosynthesis, 5-lipoxygenase (5-LO) with either a 5-LO inhibitor or through inhibition 
of the 5-LO activating protein (FLAP)(59), significantly reduces the severity of EIB 
(60). Since LT receptor antagonists (LTRAs) that block the Cys-LT1 receptor 
similarly reduce the severity of EIB (29, 60), LTD4 is likely to mediate 
bronchoconstriction (as LTD4 is the primary agonist for the CysLT1 receptor). 
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However, the inhibition of EIB by LT modifiers is incomplete, implicating other 
bronchoconstrictive eicosanoids [such as PGD2 and 15S-Hydroxyeicosatetranoic Acid 
(15S-HETE)], and/or the reduction in bronchoprotective mediators (such as PGE2). 
PGD2 binds to two major receptors; DP1 and DP2, or CRTH2. There has been intense 
interest in development of CRTH2 inhibitors in chronic asthma because this receptor 
serves as a key regulator of leukocyte activation, but the results of such inhibitors for 
treatment of stable asthma have been modest (61). With respect to EIB, the DP1 
receptor may serve as the key receptor mediating bronchoconstriction and cough, as 
the DP1 receptor serves as a key activator of capsaicin sensitive sensory neurons (see 
below)(62).  
 
Although mediators that initiate bronchoconstriction directly are largely attributed to 
products derived by leukocytes, the epithelium can directly release mediators, such as 
15S-HETE, and can serve as a source of the initial products of eicosanoid metabolism, 
leading to leukocyte-derived mediators by transcellular metabolism. In some cases, 
these alterations in eicosanoid synthesis can lead to shunting of arachidonic acid (AA) 
away from the production of PGE2 and to an imbalance between the pro-
inflammatory mediators, such as Cys-LTs relative to PGE2 (63). In addition to 
shunting of AA away from PGE2 production, there are other alterations in the 
epithelium under the influence of IL-13 that reduce the production of PGE2 (64).  
 
Mast cells and eosinophils are strongly implicated as the cellular sources of Cys-LTs 
and other eicosanoids (such as PGD2) in EIB. Following exercise challenge, 
histamine and the mast cell protease tryptase are released into the airways, 
demonstrating mast cell degranulation (29). The eosinophil product eosinophilic 
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cationic protein (ECP) is released into the airways following challenge, and the 
amount of ECP release varies with the severity of the EIB under different 
experimental conditions (56). In an analogous situation, pharmacological inhibitors 
administered prior to mannitol challenge revealed that histamine and possibly PGD2 
are responsible for the early onset of bronchoconstriction, (30, 31, 65), while the 
release of CysLTs is responsible for sustained bronchoconstriction (30, 66).  
 
The cellular and molecular phenotype associated with EIB 
The susceptibility to develop bronchoconstriction in response to hyperpnea challenge 
varies widely among subjects with established asthma and among individuals without 
a prior diagnosis of asthma. Thus, the presence of EIB following a specific challenge 
tests represents clinically recognizable phenotype of asthma. Recent work to 
understand the biological basis of this syndrome has revealed a consistent biological 
endotype related to cellular inflammation, particularly the density or mast cells in the 
airway epithelium (67, 68). Quantitative morphometry of airway biopsies, using 
design-based stereology, showed that the density of mast cells localized to the airway 
epithelium is significantly higher in subjects with EIB relative to individuals without 
asthma and those with asthma who do not have EIB (Figure 4 A&B) (69). Genome-
wide expression studies of airway epithelial samples have also revealed high 
expression of the mast cell genes tryptase and carboxypeptidase A3 (CPA3), but low 
expression of chymase (Figure 4 C&D) (69, 70). This unique intraepithelial mast cell 
phenotype is also a biomarker of the “Th2 high” molecular phenotype of asthma (71, 
72) that is IL-13 mediated (73, 74). The association between airway eosinophilia and 
the severity of EIB also provides evidence of this association with “type-2” 
inflammation (36, 75). Further, modifications of airway proteins that reflect 
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eosinophil activation are associated with the severity of EIB (76). Individuals with 
EIB have higher levels of Cys-LTs in induced sputum (36) and in exhaled breath 
condensate (EBC) (77). Higher levels of Cys-LTs in this group likely reflects the 
ability of mast cells and eosinophils to direct the eicosanoid pathway towards the 
synthesis of Cys-LTs as these cells are the predominant source of LTC4 synthase 
(LTC4S), the key enzyme directing this pathway towards Cys-LT formation in the 
airways (78). The rate-limiting step in eicosanoid formation occurs at the initial 
release of AA by the hydrolysis of the sn-2 position of membrane phospholipids by a 
family of phospholipase A2 (PLA2) enzymes. Although the cytosolic PLA2s are 
known to serve this regulatory function, recent work has revealed that secreted PLA2 
(sPLA2) activity is increased in asthma and is predominantly derived from sPLA2 
groups IIA and X (i.e., sPLA2-IIA and sPLA2-X) (63, 79). Further work has revealed 
that the level of sPLA2-X is elevated in the airways of subjects with asthma, and tends 
to be higher in subjects with EIB (Figure 5) (80). In addition, sPLA2-X is post-
translationally activated by transglutaminase 2 (TGM2), an enzyme that is 
overexpressed in the airways of patients with EIB (70). As the key source of sPLA2-X 
is the epithelium, and the enzyme can serve as an activator of myeloid cells, such as 
eosinophils, to generate the production of Cys-LTs (81), these results raise the 
possibility that sPLA2-X serves as a critical initiator of eicosanoid production in 
response to exercise-hyperpnea.  
 
Other markers of airway inflammation have also been associated with EIB, including 
an increase in the fraction of exhaled nitric oxide (FENO) (82), especially in subjects 
with atopy (83). The levels of 8-isoprostanes, non-enzymatic products of phospholipid 
oxidation, are increased in EBC of asthmatics with EIB, and correlated with the 
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severity of EIB (84). A reduction in the level of the protective eicosanoid lipoxin A4 
has also been described in EIB (85).  
 
In summary, patients who are susceptible to EIB have epithelial shedding, 
overproduction of inflammatory mediators, such as Cys-LTs, relative underproduction 
of protective lipid mediators, and infiltration of the airways with eosinophils and mast 
cells (Figure 2). 
 
Refractoriness to repeated exercise  
A refractory period after EIB for ~2 hours occurs in 50 to 60% of people with asthma. 
This refractoriness is not due to a reduction in heat or water loss from the airways 
with repeated exercise. Many theories have been suggested to explain 
refractoriness.(86) The most compelling involve release of mediators during exercise 
and their sustained presence after exercise. One theory relates to the bronchodilator 
effect of PGE2 and the second relates to development of tolerance to the mediators of 
bronchoconstriction, particularly to the cyst-LTs. The finding that non-steroidal anti-
inflammatory agent indomethacin could prevent refractoriness to EIB was explained 
on the basis of blocking production of PGE2 during initial challenge.(87)  It is also 
known that refractoriness to exercise occurs after challenge with LTD4.(88) Increased 
levels of PGE2 has recently been reported during the refractory period following 
hyperpnea of dry air.(89)  It has been proposed that repeated stimulation of the cyst-
LT receptors lead to their internalisation on the bronchial smooth muscle that would 
explain refractoriness. When mediators were measured in response to repeated 
challenge with inhaled mannitol, the subjects most refractory to the second challenge 
had significantly higher levels of mediators following challenge.(90) Both 
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prostaglandins and leukotrienes work through G protein coupled receptors and the 
events proposed to explain refractoriness are illustrated in Figure 6.(86) 
 
NEUROGENIC FACTORS AND EIB 
Sensory nerve activation 
The airways are innervated by network of sensory nerves that sense mechanical, 
nociceptive and inflammatory signals through afferent C and A fibers. These sensory 
neurons send signals centrally, leading to a coordinated response with the efferent 
parasympathetic nervous system (see below), as well as through a local reflex called 
retrograde axonal transmission. It is becoming increasingly clear that airway 
hyperresponsiveness (AHR) is mediated through alterations in both the sensory and 
autonomic nervous system pathways in the airways (91). This neural plasticity in 
asthma is the result of changes in the composition of the different types of sensory 
neurons, the production of neurokinins, such as neurokinin A (NKA) and substance P 
(SP), and the density of transient receptor potential (TRP) channels, such as TRP 
vanilloid receptor 1 (TRPV1) which serves as the receptor for capsaicin. These 
changes are the consequence of chronic inflammation and the generation of 
neurotropins, such as nerve growth factor (92). In murine models, the sensory neurons 
are required for the development of AHR (93). The precise anatomical changes in the 
sensory nervous system of the airways in human asthma are not known in detail; 
however, the threshold for activation of the sensory nerves by the TRPV1 agonist 
capsaicin is lowered in asthma (94). 
 
In animal models of EIB, it is well established that the sensory nerves mediate 
bronchoconstriction in response to a period of dry air hyperpnea, and that the 
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generation of leukocyte-derived eicosanoids plays the dominant role in activating this 
neural pathway. In a guinea pig model of hyperpnea-induced bronchoconstriction 
(HIB), inhibition of Cys-LT signaling, with either a 5-LO inhibitor or a LTRA, 
inhibited HIB and the release of neurokinins, while a neurokinin 2 receptor antagonist 
inhibited HIB, but not the release of leukotrienes, suggesting that leukotrienes cause 
bronchoconstriction via sensory nerves during HIB (95). In a dog model, a 
combination neurokinin 1 and 2 receptor antagonist inhibited HIB and the generation 
of LTs that are known in this model to cause HIB (96). Sensory nerves are activated 
directly by osmotic stimuli, but several eicosanoids can either directly activate or alter 
the activation threshold of sensory nerves (97). A recent study demonstrated that 
PGD2, which is predominantly derived from mast cells, initiates sensory nerve 
activation through the DP1 receptor, regulating airway tone (62). Although the 
function of neurokinins during EIB has not been fully tested, there is evidence that the 
levels of NKA and Cys-LTs in the airways are correlated with the amount of 
bronchoconstriction following exercise challenge and with the release of MUC5AC 
(50). Overall, these findings suggest that in humans, bronchoconstriction and mucus 
release following exercise challenge is the consequence of sensory nerve activation 
that is initiated by the release of eicosanoids from airway leukocytes, such as mast 
cells.  
 
THE ROLE OF REGIONAL ALTERATIONS IN THE AIRWAYS AND THE 
DEVELOPMENT OF EIB  
In model systems, particularly in animal models with either airway injury or inflamed 
airways, the mechanism leading to AHR includes regional altertions in airway 
diameter that are heterogenous, leading to regional airway closure that contributes to 
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the development of airflow obstruction (98, 99). With the use of hyperpolarized 
helium imaging to assess regional ventilation, it is apparent that the development of 
airflow obstruction after exercise represents heterogeneous effects on airway caliber, 
ranging from conducting airway narrowing to frank airway closure (100). Treatment 
to reduce the severity of EIB reduces these heterogeneous regional defects in 
ventilation (101). These findings suggest that the stimulus for EIB causes 
bronchoconstriction in regions of the airways that are specifically susceptible to this 
stimulus, most likely because of alterations in the airway wall related to aiway 
inflammation. Such regional alterations in ventilation are also known to be present at 
baseline in subjects with asthma, and are associated with the severity of asthma (102). 
There is evidence that areas of regional heterogeneity in ventilation tend to persist 
over time, further suggesting that these regions of the airways have heightened 
susceptibility to airway narrowing (103). Additional studies are needed to fully 
understand the nature of these regional alterations in airway structure and airway 
dysfunction in humans.  
 
SUMMARY/FUTURE CONSIDERATIONS 
Water evaporation from the airways and thermal changes during exercise-hyperpnea 
are well established stimuli to EIB. In recents years, it has become increasingly clear 
that a dysfunctional airway epithelium – characterised by a loss of physical barrier 
integrity and impairment in signaling and secretory functions – renders individuals 
with asthma, as well as elite athletes susceptible to EIB. In these two populations, 
lipid mediator release (cys-LTs and PGD2) has repeatedly been observed in response 
to exercise challenge (or its surrogates), highlighting the inflammatory nature of the 
condition. Additional work is warranted to define the exact role of sensory nerves and 
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of regional alterations in ventilation in the pathogenesis of EIB. As EIB represents a 
precise asthma phenotype that can be characterized clinically, and is associated with 
an increasingly well defined biological endotype, these findings should prove useful 
to target therapy for this important aspect of asthma.  
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Figure1. Both airway cooling and mucosal dehydration occur in response to 
evaporative water loss from the airway surface. These events lead to exercise-induced 
bronchoconstriction. The figure is taken from Rundell et al. (1), and modified, with 
permission, from the original by Anderson and Daviskas (24). 
 
Figure 2. Cells involved in exercise-induced bronchoconstriction. The epithelial cell 
layer is the source of prostaglandin E2, a bronchodilating prostaglandin. The levels 
are lower in asthmatics. The mast cells are the source of prostaglandin D2 and 
cysteinyl leukotrienes and eosinophils are also a source of cysteinyl leukotrienes.  
These bronchoconstricting mediators likely act via sensory nerves to cause smooth 
muscle contraction and airway narrowing. This has been demonstrated indirectly by 
the increase in leukotrienes being related to the increase in mucin (MUC5A) released 
from goblet cells and the release of neurokin A. The bronchial smooth muscle may 
also be stimulated directly by some of these same mediators. The figure is taken from 
Rundell et al. (1), and modified, with permission, from the original by Hallstrand et 
al. (104). 
 
Figure 3. The severity of the bronchoconstriction after exercise is similar in the same 
individual over a wide range of inspired air temperatures. Panel A drawn from Deal et 
al., (2), with the reduction in forced expiratory volume in 1 sec (FEV1) after exercise 
expressed as percentage of the pre-exercise level; Panel B drawn from Hahn et al. (8), 





Figure 4. Mast cell infiltration of the airway epithelium in asthma. Quantitative 
morphometry of endobronchial biopsy samples and epithelial brush gene expression 
from individuals without asthma (Ctrl) compared with individuals with asthma and 
EIB (EIB+) and individuals with asthma without EIB (EIB-). Quantitative 
morphometry reveals that the number of mast cells per volume of airway epithelium 
(A) and the number of mast cells per area of the basal lamina (B) are substantially 
increased in individuals with EIB compared to asthmatics without EIB and normal 
controls. Epithelial brushings show a pattern of mast cell gene expression of tryptase 
(C) and CPA3 (D) with high expression of these genes in EIB, but lower expression 
of Chymase (data not shown). Adapted from Lai et al. (69), with permission.  
 
Figure 5. Secreted phospholipase A2 (sPLA2-X) protein levels in the airways in 
asthma. Quantitative assessment of sPLA2-X protein levels in induced sputum 
supernatant and lysates of epithelial brushings from the lower airways in individuals 
without asthma (Ctrl) compared with individuals with asthma and EIB (EIB+) and 
individuals with asthma without EIB (EIB-). Induced sputum levels of sPLA2-X were 
elevated in asthma, particularly in individuals with EIB (A). The levels of sPLA2-X in 
the epithelium were elevated only in the asthma group with EIB (B). Adapted from 
Hallstrand et al. (80), with permission.  
 
Figure 6.  Desensitization of Cys-LT1 as a mechanism of refractoriness. With 
exercise, there is release of cysteinyl leukotrienes from mast cells that stimulate the 
GPCR Cys-LT1 causing contraction of the muscle and exercise-induced 
bronchoconstriction. The PGs generated during the same exercise could, via 
stimulation of the GPCRs DP1/EP1-4/TP, lead to crosstalk so that the Cys-LT1 is 
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desensitized through phosphorylation and internalization. Refractoriness to a second 
exercise challenge within a short period occurs as a result. When the levels of 
mediators return to baseline values, the Cys-LT1 receptors are recycled back to the 
cell surface and the muscle becomes sensitive to further stimulation. When generation 
of PGs is inhibited by agents, such as indomethacin and flurbiprofen, then there is 
limited desensitization of the Cys-LT1 and, therefore, limited refractoriness. Cys-
LT1, cysteinyl leukotriene receptor1; DP1, prostaglandin D receptor1; EP1-4, 
prostaglandin E receptor1-4; GPCR, G-protein coupled receptor; TP, thromboxane 
receptor. From Larsson et al. (86), with permission. 
 






